- Home
- PPSI vs CALC Comparison
PPSI vs CALC Comparison
Compare PPSI & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- CALC
- Stock Information
- Founded
- PPSI 2008
- CALC 2011
- Country
- PPSI United States
- CALC United States
- Employees
- PPSI N/A
- CALC N/A
- Industry
- PPSI Electrical Products
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- PPSI Industrials
- CALC Health Care
- Exchange
- PPSI Nasdaq
- CALC Nasdaq
- Market Cap
- PPSI 46.6M
- CALC 48.1M
- IPO Year
- PPSI N/A
- CALC N/A
- Fundamental
- Price
- PPSI $4.53
- CALC $3.17
- Analyst Decision
- PPSI Strong Buy
- CALC Strong Buy
- Analyst Count
- PPSI 1
- CALC 2
- Target Price
- PPSI $12.00
- CALC $14.50
- AVG Volume (30 Days)
- PPSI 5.2M
- CALC 63.4K
- Earning Date
- PPSI 11-13-2025
- CALC 11-12-2025
- Dividend Yield
- PPSI 33.11%
- CALC N/A
- EPS Growth
- PPSI N/A
- CALC N/A
- EPS
- PPSI 2.91
- CALC N/A
- Revenue
- PPSI $31,279,000.00
- CALC N/A
- Revenue This Year
- PPSI $27.32
- CALC N/A
- Revenue Next Year
- PPSI $16.14
- CALC N/A
- P/E Ratio
- PPSI $1.53
- CALC N/A
- Revenue Growth
- PPSI 105.82
- CALC N/A
- 52 Week Low
- PPSI $2.25
- CALC $1.42
- 52 Week High
- PPSI $7.00
- CALC $5.65
- Technical
- Relative Strength Index (RSI)
- PPSI 68.06
- CALC 53.86
- Support Level
- PPSI $3.65
- CALC $3.00
- Resistance Level
- PPSI $3.97
- CALC $3.73
- Average True Range (ATR)
- PPSI 0.27
- CALC 0.31
- MACD
- PPSI 0.06
- CALC 0.04
- Stochastic Oscillator
- PPSI 92.56
- CALC 46.67
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.